Tags

Type your tag names separated by a space and hit enter

Crosslinked Hyaluronic Acid Gels for the Prevention of Intrauterine Adhesions after a Hysteroscopic Myomectomy in Women with Submucosal Myomas: A Prospective, Randomized, Controlled Trial.
Life (Basel). 2020 May 15; 10(5)L

Abstract

Intrauterine adhesion (IUA), fibrosis, and scarring resulting from damage to the endometrium is a rare but serious clinical disease, contributing to a significant impairment of reproductive function. Uterine instrumentation, especially that of a hysteroscopic myomectomy, has become the main cause of IUA. Therefore, a prospective randomized controlled study to assess the effectiveness and short-term safety of the use of hyaluronic acid gels in the prevention of IUA after a hysteroscopic myomectomy and an evaluation of the characteristics of IUA observed at follow-up are presented here. A total of 70 patients were analyzed at the end of 16 March 2020. The results show that the incidence of IUA in women who underwent a hysteroscopic myomectomy is 21.4% (15/70), overall. Women treated with hyaluronic acid gels have a statistically significantly lower incidence of IUAs than non-treated women (12.8% vs. 39.1%, p = 0.012). In addition, women in the anti-adhesive gel treatment group had a dramatically reduced severity of IUA than women in the no-treatment group (p = 0.002). Further analysis shows that the International Federation of Gynecology and Obstetrics (FIGO) classification type and the use of anti-adhesive gels are independent factors associated with moderate and severe degrees of IUA formation. The results here highlight the significant therapeutic benefits of the application of hyaluronic acid gels in women undergoing a hysteroscopic myomectomy, especially for those patients with a uterine myoma classified as FIGO type 2. Since the risk of IUA after a hysteroscopic myomectomy is high, especially for patients who have not received prophylactic anti-adhesive gels, the application of hyaluronic acid gels as a prevention strategy is highly recommended. More studies are encouraged to confirm our observation.

Authors+Show Affiliations

Department of Obstetrics and Gynecology, Taipei Veterans General Hospital, Taipei 112, Taiwan. Institute of Clinical Medicine, National Yang-Ming University, Taipei 112, Taiwan. Department of Obstetrics and Gynecology, National Yang-Ming University, Taipei 112, Taiwan.Department of Obstetrics and Gynecology, Taipei Veterans General Hospital, Taipei 112, Taiwan. Institute of Clinical Medicine, National Yang-Ming University, Taipei 112, Taiwan. Department of Nursing, Taipei Veterans General Hospital, Taipei 112, Taiwan.Department of Obstetrics and Gynecology, Taipei Veterans General Hospital, Taipei 112, Taiwan. Institute of Clinical Medicine, National Yang-Ming University, Taipei 112, Taiwan. Department of Obstetrics and Gynecology, National Yang-Ming University, Taipei 112, Taiwan.Biostatics Task Force, Taipei Veterans General Hospital, Taipei 112, Taiwan.Department of Obstetrics and Gynecology, Taipei Veterans General Hospital, Taipei 112, Taiwan. Institute of Clinical Medicine, National Yang-Ming University, Taipei 112, Taiwan. Department of Obstetrics and Gynecology, National Yang-Ming University, Taipei 112, Taiwan.Department of Obstetrics and Gynecology, Taipei Veterans General Hospital, Taipei 112, Taiwan. Institute of Clinical Medicine, National Yang-Ming University, Taipei 112, Taiwan. Department of Obstetrics and Gynecology, National Yang-Ming University, Taipei 112, Taiwan.Institute of Clinical Medicine, National Yang-Ming University, Taipei 112, Taiwan. Department of Medicine, Cheng-Hsin General Hospital, Taipei 112, Taiwan. Department of Nursing, Oriental Institute of Technology, New Taipei City 220, Taiwan.Department of Obstetrics and Gynecology, Taipei Veterans General Hospital, Taipei 112, Taiwan. Institute of Clinical Medicine, National Yang-Ming University, Taipei 112, Taiwan. Department of Obstetrics and Gynecology, National Yang-Ming University, Taipei 112, Taiwan. Female Cancer Foundation, Taipei 104, Taiwan. Department of Medical Research, China Medical University Hospital, Taichung 404, Taiwan.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

32429137

Citation

Huang, Chen-Yu, et al. "Crosslinked Hyaluronic Acid Gels for the Prevention of Intrauterine Adhesions After a Hysteroscopic Myomectomy in Women With Submucosal Myomas: a Prospective, Randomized, Controlled Trial." Life (Basel, Switzerland), vol. 10, no. 5, 2020.
Huang CY, Chang WH, Cheng M, et al. Crosslinked Hyaluronic Acid Gels for the Prevention of Intrauterine Adhesions after a Hysteroscopic Myomectomy in Women with Submucosal Myomas: A Prospective, Randomized, Controlled Trial. Life (Basel, Switzerland). 2020;10(5).
Huang, C. Y., Chang, W. H., Cheng, M., Huang, H. Y., Horng, H. C., Chen, Y. J., Lee, W. L., & Wang, P. H. (2020). Crosslinked Hyaluronic Acid Gels for the Prevention of Intrauterine Adhesions after a Hysteroscopic Myomectomy in Women with Submucosal Myomas: A Prospective, Randomized, Controlled Trial. Life (Basel, Switzerland), 10(5). https://doi.org/10.3390/life10050067
Huang CY, et al. Crosslinked Hyaluronic Acid Gels for the Prevention of Intrauterine Adhesions After a Hysteroscopic Myomectomy in Women With Submucosal Myomas: a Prospective, Randomized, Controlled Trial. Life (Basel, Switzerland). 2020 May 15;10(5) PubMed PMID: 32429137.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Crosslinked Hyaluronic Acid Gels for the Prevention of Intrauterine Adhesions after a Hysteroscopic Myomectomy in Women with Submucosal Myomas: A Prospective, Randomized, Controlled Trial. AU - Huang,Chen-Yu, AU - Chang,Wen-Hsun, AU - Cheng,Min, AU - Huang,Hsin-Yi, AU - Horng,Huann-Cheng, AU - Chen,Yi-Jen, AU - Lee,Wen-Ling, AU - Wang,Peng-Hui, Y1 - 2020/05/15/ PY - 2020/04/20/received PY - 2020/05/10/revised PY - 2020/05/13/accepted PY - 2020/5/21/entrez PY - 2020/5/21/pubmed PY - 2020/5/21/medline KW - anti-adhesive gel KW - hyaluronic acid KW - hysteroscopic myomectomy KW - intrauterine adhesion KW - prevention KW - reduction JF - Life (Basel, Switzerland) VL - 10 IS - 5 N2 - Intrauterine adhesion (IUA), fibrosis, and scarring resulting from damage to the endometrium is a rare but serious clinical disease, contributing to a significant impairment of reproductive function. Uterine instrumentation, especially that of a hysteroscopic myomectomy, has become the main cause of IUA. Therefore, a prospective randomized controlled study to assess the effectiveness and short-term safety of the use of hyaluronic acid gels in the prevention of IUA after a hysteroscopic myomectomy and an evaluation of the characteristics of IUA observed at follow-up are presented here. A total of 70 patients were analyzed at the end of 16 March 2020. The results show that the incidence of IUA in women who underwent a hysteroscopic myomectomy is 21.4% (15/70), overall. Women treated with hyaluronic acid gels have a statistically significantly lower incidence of IUAs than non-treated women (12.8% vs. 39.1%, p = 0.012). In addition, women in the anti-adhesive gel treatment group had a dramatically reduced severity of IUA than women in the no-treatment group (p = 0.002). Further analysis shows that the International Federation of Gynecology and Obstetrics (FIGO) classification type and the use of anti-adhesive gels are independent factors associated with moderate and severe degrees of IUA formation. The results here highlight the significant therapeutic benefits of the application of hyaluronic acid gels in women undergoing a hysteroscopic myomectomy, especially for those patients with a uterine myoma classified as FIGO type 2. Since the risk of IUA after a hysteroscopic myomectomy is high, especially for patients who have not received prophylactic anti-adhesive gels, the application of hyaluronic acid gels as a prevention strategy is highly recommended. More studies are encouraged to confirm our observation. SN - 2075-1729 UR - https://www.unboundmedicine.com/medline/citation/32429137/Crosslinked_Hyaluronic_Acid_Gels_for_the_Prevention_of_Intrauterine_Adhesions_after_a_Hysteroscopic_Myomectomy_in_Women_with_Submucosal_Myomas:_A_Prospective_Randomized_Controlled_Trial_ L2 - https://www.mdpi.com/resolver?pii=life10050067 DB - PRIME DP - Unbound Medicine ER -
Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.